These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18565681)
1. Inhalation of divalent and trivalent manganese mixture induces a Parkinson's disease model: immunocytochemical and behavioral evidences. Ordoñez-Librado JL; Gutierrez-Valdez AL; Colín-Barenque L; Anaya-Martínez V; Díaz-Bech P; Avila-Costa MR Neuroscience; 2008 Jul; 155(1):7-16. PubMed ID: 18565681 [TBL] [Abstract][Full Text] [Related]
2. L-DOPA treatment reverses the motor alterations induced by manganese exposure as a Parkinson disease experimental model. Ordoñez-Librado JL; Anaya-Martinez V; Gutierrez-Valdez AL; Montiel-Flores E; Corona DR; Martinez-Fong D; Avila-Costa MR Neurosci Lett; 2010 Mar; 471(2):79-82. PubMed ID: 20079802 [TBL] [Abstract][Full Text] [Related]
3. Manganese mixture inhalation is a reliable Parkinson disease model in rats. Sanchez-Betancourt J; Anaya-Martínez V; Gutierrez-Valdez AL; Ordoñez-Librado JL; Montiel-Flores E; Espinosa-Villanueva J; Reynoso-Erazo L; Avila-Costa MR Neurotoxicology; 2012 Oct; 33(5):1346-55. PubMed ID: 22975423 [TBL] [Abstract][Full Text] [Related]
4. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Iancu R; Mohapel P; Brundin P; Paul G Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062 [TBL] [Abstract][Full Text] [Related]
6. Basal Ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse. Dodd CA; Ward DL; Klein BG Int J Toxicol; 2005; 24(6):389-97. PubMed ID: 16393931 [TBL] [Abstract][Full Text] [Related]
7. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]
8. Assessment of bioaccumulation, neuropathology, and neurobehavior following subchronic (90 days) inhalation in Sprague-Dawley rats exposed to manganese phosphate. Normandin L; Carrier G; Gardiner PF; Kennedy G; Hazell AS; Mergler D; Butterworth RF; Philippe S; Zayed J Toxicol Appl Pharmacol; 2002 Sep; 183(2):135-45. PubMed ID: 12387753 [TBL] [Abstract][Full Text] [Related]
9. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291 [TBL] [Abstract][Full Text] [Related]
10. Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons. Yang Y; An J; Wang Y; Luo W; Wang W; Mei X; Wu S; Chen J Environ Toxicol Pharmacol; 2011 Jan; 31(1):171-8. PubMed ID: 21787683 [TBL] [Abstract][Full Text] [Related]
11. Uptake, distribution and behavioral effects of inhalation exposure to manganese (MnO2) in the adult mouse. Morganti JB; Lown BA; Stineman CH; D'Agostino RB; Massaro EJ Neurotoxicology; 1985; 6(1):1-15. PubMed ID: 3873032 [TBL] [Abstract][Full Text] [Related]
12. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367 [TBL] [Abstract][Full Text] [Related]
13. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Yong VW; Perry TL; Godolphin WJ; Jones KA; Clavier RM; Ito M; Foulks JG Neurotoxicology; 1986; 7(1):19-24. PubMed ID: 2872639 [TBL] [Abstract][Full Text] [Related]
14. Involvement of striatal lipid peroxidation and inhibition of calcium influx into brain slices in neurobehavioral alterations in a rat model of short-term oral exposure to manganese. Avila DS; Gubert P; Fachinetto R; Wagner C; Aschner M; Rocha JB; Soares FA Neurotoxicology; 2008 Nov; 29(6):1062-8. PubMed ID: 18778733 [TBL] [Abstract][Full Text] [Related]
15. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease. Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705 [TBL] [Abstract][Full Text] [Related]
16. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta. Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743 [TBL] [Abstract][Full Text] [Related]
17. [The comparison of neurobehavioral changes and impaired locations between the mouse model of manganism and Parkinson's disease]. Dou CS; Zhi CN; Liu WL; Fu JL; Yao BY Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Feb; 36(2):84-90. PubMed ID: 29699003 [No Abstract] [Full Text] [Related]
18. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model. Willis GL; Kelly AM; Kennedy GA Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659 [TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease. Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945 [TBL] [Abstract][Full Text] [Related]
20. Interaction of curcumin with manganese may compromise metal and neurotransmitter homeostasis in the hippocampus of young mice. Schmitz AE; de Oliveira PA; de Souza LF; da Silva DG; Danielski S; Santos DB; de Almeida EA; Prediger RD; Fisher A; Farina M; Dafre AL Biol Trace Elem Res; 2014 Jun; 158(3):399-409. PubMed ID: 24723215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]